E-LIB Suche - Ergebnisse für: Gottlieb, A.B.

1

P50 Increasingly Stringent Clinical Responses and the Assoc..:

Gottlieb, A.B. ; Mørup, M. ; Davis, L....
Value in Health. 27 (2024) 6 - p. S12 , 2024

Link: https://doi.org/10.1016/..

2

CO13 A Claims Analysis To Characterize All-Cause Mortality ..:

Gottlieb, A.B. ; Kwiatkowski, H. ; Lavasani, L...
Value in Health. 27 (2024) 6 - p. S18 , 2024

Link: https://doi.org/10.1016/..

3

EE162 A Claims Analysis to Characterize the Economic Burden..:

Gottlieb, A.B. ; Lavasani, L ; Kwiatkowski, H.
Value in Health. 27 (2024) 6 - p. S87 , 2024

Link: https://doi.org/10.1016/..

4

Health‐related quality of life in patients with generalized..:

Choon, S. E. ; De La Cruz, C. ; Wolf, P....
Journal of the European Academy of Dermatology and Venereology. 38 (2023) 2 - p. 265-280 , 2023

Link: https://doi.org/10.1111/..

5

MSR52 Defining Severity Category Thresholds to Guide Psoria..:

Augustin, M. ; Gottlieb, A.B. ; Warham, R....
Value in Health. 26 (2023) 12 - p. S402-S403 , 2023

Link: https://doi.org/10.1016/..

6

MSR85 Psoriasis Symptoms and Impacts Measure: Identifying K..:

Warren, R.B. ; Augustin, M. ; Warham, R....
Value in Health. 26 (2023) 12 - p. S409 , 2023

Link: https://doi.org/10.1016/..

7

Efficacy of secukinumab and adalimumab in patients with pso..:

Gottlieb, A.B. ; Merola, J.F. ; Reich, K....
British Journal of Dermatology. 185 (2021) 6 - p. 1124-1134 , 2021

Link: https://doi.org/10.1111/..

8

Long‐term efficacy of certolizumab pegol for the treatment ..:

Gordon, K.B. ; Warren, R.B. ; Gottlieb, A.B....
British Journal of Dermatology. 184 (2020) 4 - p. 652-662 , 2020

Link: https://doi.org/10.1111/..

9

A study of the drug secukinumab in the treatment of palmopl..:

Gottlieb, A.B. ; Kubanov, A. ; Doorn, M....
British Journal of Dermatology. 182 (2020) 4 - p. , 2020

Link: https://doi.org/10.1111/..

10

苏金单抗治疗掌跖银屑病的研究:

Gottlieb, A.B. ; Kubanov, A. ; Doorn, M....
British Journal of Dermatology. 182 (2020) 4 - p. , 2020

Link: https://doi.org/10.1111/..

11

PBI56 Psychometric Validation of the P-SIM, a NOVEL Patient..:

Warren, R.B. ; Gottlieb, A.B. ; Merola, J.F....
Value in Health. 23 (2020) - p. S420 , 2020

Link: https://doi.org/10.1016/..

12

Long‐term safety of certolizumab pegol in plaque psoriasis:..:

Blauvelt, A. ; Paul, C. ; Kerkhof, P....
British Journal of Dermatology. 184 (2020) 4 - p. 640-651 , 2020

Link: https://doi.org/10.1111/..

13

Older adults on systemic treatment for psoriasis and risk o..:

Schneeweiss, M.C. ; Perez Chada, L. ; Gottlieb, A.B..
British Journal of Dermatology. 183 (2020) 3 - p. 564-566 , 2020

Link: https://doi.org/10.1111/..

14

Inter‐rater agreement and reliability of outcome measuremen..:

Thorlacius, L. ; Garg, A. ; Riis, P.T....
British Journal of Dermatology. 181 (2019) 3 - p. 483-491 , 2019

Link: https://doi.org/10.1111/..

15

Open‐label, investigator‐initiated, single‐site exploratory..:

Prussick, L. ; Rothstein, B. ; Joshipura, D....
British Journal of Dermatology. 181 (2019) 3 - p. 609-611 , 2019

Link: https://doi.org/10.1111/..